Overall rank by patents
#3,267
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Singular Genomics Systems, Inc.
USPTO PatentsView assignee record — 115 granted patents across 26 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
115
Total patents granted
26
CPC technology areas
19.6
Avg claims per patent
—
5-year filing velocity
The verdict
Singular holds 115 US patents across 26 technology areas — rank #3,267 of 50,000 tracked assignees.
- #3,267
- of 50,000 US assignees by volume
- Top 1%
- by Innovation Score (66.2/100)
- 19.6
- avg claims per patent
Portfolio overview
Singular Genomics Systems, Inc. has been granted 115 US utility patents between 2020 and 2025, placing Singular Genomics Systems, Inc. at rank #3,267 across all assignees tracked by PlainPatent. This portfolio spans 26 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.6 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Singular Genomics Systems, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 66.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 115 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Singular Genomics Systems, Inc.'s 19.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 26 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Singular Genomics Systems, Inc. against peers pursuing similar technology classes.
How does Singular compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Singular Genomics… ◀ 115
Singular Genomics Systems, Inc.
115 patents
What this shows Singular holds 115 patents — placing it at rank #3,267 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Singular's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
66 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025
USPTO utility patent grants by year · 2020–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 1.7% |
| 2021 | 5 | 4.3% |
| 2022 | 15 | 13.0% |
| 2023 | 25 | 21.7% |
| 2024 | 41 | 35.7% |
| 2025 | 27 | 23.5% |
Which technologies does Singular Genomics Systems, Inc. patent most?
Top 15 of 26 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Frequently Asked Questions
How many patents does Singular Genomics Systems, Inc. hold?
Singular Genomics Systems, Inc. holds 115 US granted patents filed between 2020 and 2025, spanning 26 technology areas.
What is Singular Genomics Systems, Inc.'s Innovation Score?
Singular Genomics Systems, Inc. has an Innovation Score of 66.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Singular Genomics Systems, Inc. focus on?
Singular Genomics Systems, Inc.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 75 patents. The company has filed patents in 26 CPC subclasses total.
Is Singular Genomics Systems, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Singular Genomics Systems, Inc..
What does claim depth mean for Singular Genomics Systems, Inc.'s patents?
Singular Genomics Systems, Inc.'s patents average 19.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Singular Genomics Systems, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
C12Q technology
Singular Genomics Systems, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Singular Genomics Systems, Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
